{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:09:04Z","timestamp":1785150544356,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Tenax pharmaceuticals"},{"DOI":"10.13039\/100006513","name":"Duke Clinical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006513","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tenax Therapeutics"},{"name":"Tenax Therapeutics"},{"name":"Bernard S. Goldman Chair in Cardiovascular Surgery"},{"name":"Fresenius Kabi"},{"name":"Tenax Therapeutics"},{"name":"Tenax Therapeutics"},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Lilly","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tenax Therapeutics"},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Merck & Company"},{"name":"Oxygen Therapeutics"},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CryoLife"},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tenax Therapeutics"},{"name":"VoluMetrix"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jtcvs.2019.06.020","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T08:16:00Z","timestamp":1561104960000},"page":"2302-2309.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery"],"prefix":"10.1016","volume":"159","author":[{"given":"Sean","family":"van Diepen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra H.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Leimberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun G.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Fremes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Jankowich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Heringlake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Anstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Luber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Dave","family":"Nagpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andra E.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Argenziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Toller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. David","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato D.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Cowper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Mark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2019.06.020_bib1","doi-asserted-by":"crossref","first-page":"I344","DOI":"10.1161\/CIRCULATIONAHA.104.526277","article-title":"Coronary artery bypass grafting in patients with low ejection fraction","volume":"112","author":"Topkara","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.athoracsur.2009.05.053","article-title":"The\u00a0Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1\u2014coronary artery bypass grafting surgery","volume":"88","author":"Shahian","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib3","first-page":"125","article-title":"Preoperative levosimendan decreases mortality and the development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass","volume":"17","author":"Levin","year":"2012","journal-title":"Exp Clin Cardiol"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib4","first-page":"CD009669","article-title":"Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome","volume":"1","author":"Schumann","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijcard.2015.02.022","article-title":"Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion","volume":"184","author":"Toller","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/01.fjc.0000137163.22359.17","article-title":"Effect of levosimendan on balance between ATP production and consumption in isolated perfused guinea-pig heart before ischemia or after reperfusion","volume":"44","author":"Eriksson","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1067\/mcp.2000.110972","article-title":"Myocardial efficiency during levosimendan infusion in congestive heart failure","volume":"68","author":"Ukkonen","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1017\/S0265021507002736","article-title":"Effects of levosimendan on myocardial ischaemia-reperfusion injury","volume":"25","author":"Yapici","year":"2008","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib9","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1161\/01.CIR.0000159252.82444.22","article-title":"Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake","volume":"111","author":"Michaels","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib10","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1616218","article-title":"Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery","volume":"376","author":"Mehta","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2016.09.001","volume":"182","author":"Mehta","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/01.CIR.61.3.508","article-title":"Clinical judgment and statistics. Lessons from a simulated randomized trial in coronary artery disease","volume":"61","author":"Lee","year":"1980","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib13","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib14","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1136\/bmj.317.7167.1195","article-title":"Analysis and interpretation of cost data in randomised controlled trials: review of published studies","volume":"317","author":"Barber","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hec.699","article-title":"Assessing and comparing costs: how robust are the bootstrap and methods based on asymptotic normality?","volume":"12","author":"O'Hagan","year":"2003","journal-title":"Health Econ"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1469-1809.1955.tb01285.x","article-title":"The estimation and significance of the logarithm of a ratiofrequencies","volume":"20","author":"Haldane","year":"1956","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijcard.2011.07.022","article-title":"Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan","volume":"159","author":"Papp","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib18","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.bcp.2004.05.018","article-title":"Potassium-specific effects of levosimendan on heart mitochondria","volume":"68","author":"Kopustinskiene","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2003.12.006","article-title":"Stereoselective binding of levosimendan to cardiac troponin C causes Ca2+-sensitization","volume":"486","author":"Sorsa","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib20","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/euhj.1997.0806","article-title":"Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting","volume":"19","author":"Lilleberg","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00540-019-02643-3","article-title":"The efficacy and safety of prophylactic use of levosimendan on patients undergoing coronary artery bypass graft: a systemic review and meta-analysis","volume":"33","author":"Wang","year":"2019","journal-title":"J Anesth"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib22","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.athoracsur.2008.10.029","article-title":"Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function","volume":"87","author":"Eriksson","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/bja\/aen367","article-title":"Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery","volume":"102","author":"Tritapepe","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib24","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1161\/CIRCULATIONAHA.108.790162","article-title":"Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery","volume":"118","author":"Fleming","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.jvca.2011.06.022","article-title":"Milrinone and mortality in adult cardiac surgery: a meta-analysis","volume":"26","author":"Zangrillo","year":"2012","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib26","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/ALN.0b013e318173026f","article-title":"Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: propensity-adjusted analyses","volume":"108","author":"Fellahi","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib27","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1053\/j.jvca.2013.03.027","article-title":"Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis","volume":"27","author":"Harrison","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib28","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0002-8703(03)00111-X","article-title":"Compared with control subjects, the systemic sympathetic nervous system\u00a0is activated in patients with mitral regurgitation","volume":"145","author":"Mehta","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib29","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0002-9149(00)01201-7","article-title":"Relation of systemic sympathetic nervous system activation to echocardiographic left ventricular size and performance and its implications in patients with mitral regurgitation","volume":"86","author":"Mehta","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib30","doi-asserted-by":"crossref","first-page":"S370","DOI":"10.1054\/jcaf.2002.129267","article-title":"Adrenergic pathways and left ventricular remodeling","volume":"8","author":"Dorn","year":"2002","journal-title":"J Card Fail"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib31","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ahj.2003.10.020","article-title":"Changes in systemic sympathetic nervous system activity after mitral valve surgery and their relationship to changes in left ventricular size and systolic performance in patients with mitral regurgitation","volume":"147","author":"Mehta","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib32","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0008-6363(99)00370-3","article-title":"Adrenergic regulation of myocardial apoptosis","volume":"45","author":"Singh","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib33","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0008-6363(97)00057-6","article-title":"The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan","volume":"34","author":"Haikala","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijcard.2017.10.077","article-title":"Perioperative levosimendan in cardiac surgery: a systematic review with meta-analysis and trial sequential analysis","volume":"251","author":"Putzu","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib35","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/jocs.13716","article-title":"Effects of levosimendan on mortality in patients undergoing cardiac surgery: a systematic review and meta-analysis","volume":"33","author":"Chen","year":"2018","journal-title":"J Card Surg"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib36","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2017.9973","article-title":"Effect\u00a0of levosimendan on low cardiac output syndrome in patients with low ejection fraction undergoing coronary artery bypass grafting with cardiopulmonary bypass: the LICORN randomized clinical trial","volume":"318","author":"Cholley","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib37","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa1616325","article-title":"Levosimendan for hemodynamic support after cardiac surgery","volume":"376","author":"Landoni","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2019.06.020_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1214\/088342306000000114","article-title":"Causal inference through potential outcomes and principal stratification: application to studies with \u201ccensoring\u201d due to death","volume":"21","author":"Rubin","year":"2006","journal-title":"Statist Sci"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522319312784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522319312784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T17:08:18Z","timestamp":1758388098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522319312784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0022522319312784"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2019.06.020","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2019.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Association for Thoracic Surgery","name":"copyright","label":"Copyright"}]}}